{"id":"thiamazol","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Agranulocytosis","Bone marrow depression","Drug-induced hepatitis","Factor II deficiency","Hypothyroidism","Leukopenia","Liver function tests abnormal","Pancytopenia","Pregnancy, function","Thrombocytopenic disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Lactoperoxidase, Taste receptor type 2 member 38, Thyroid peroxidase"},"_scrapedAt":"2026-03-28T06:28:09.616Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Hyperthyroidism","diseaseId":"hyperthyroidism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05607407","phase":"PHASE2","title":"Methimazole in Patients With Progressive Glioblastoma","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2023-01-30","conditions":"Glioblastoma, Glioma","enrollment":19},{"nctId":"NCT07369063","phase":"PHASE2","title":"Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease","status":"RECRUITING","sponsor":"Northwell Health","startDate":"2025-08-01","conditions":"Graves Disease, Graves' Disease, Hyperthyroidism","enrollment":30},{"nctId":"NCT06864351","phase":"NA","title":"Prospective Evaluation of OptiThyDose","status":"RECRUITING","sponsor":"University Children's Hospital Basel","startDate":"2025-08-28","conditions":"Thyroid Diseases, Congenital Hypothyroidism, Graves Disease","enrollment":150},{"nctId":"NCT07040306","phase":"","title":"A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China","status":"RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2012-11-14","conditions":"Graves´ Disease","enrollment":1000},{"nctId":"NCT04946123","phase":"NA","title":"Hyperthyroidism: Methimazole Plus L-carnitine and Selenium","status":"COMPLETED","sponsor":"Lo.Li.Pharma s.r.l","startDate":"2021-07-05","conditions":"Hyperthyroidism","enrollment":60},{"nctId":"NCT06240455","phase":"PHASE2","title":"Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz","status":"SUSPENDED","sponsor":"Worg Biotherapeutics Inc.","startDate":"2026-03-31","conditions":"Graves Disease","enrollment":176},{"nctId":"NCT05964452","phase":"","title":"Efficacy of Methimazole Dosing Algorithm","status":"TERMINATED","sponsor":"Cook County Health","startDate":"2022-02-14","conditions":"Graves Disease","enrollment":11},{"nctId":"NCT06570967","phase":"","title":"A Clinical Study of Hyperthyroidism in Children","status":"RECRUITING","sponsor":"Shengjing Hospital","startDate":"2023-07-18","conditions":"Hyperthyroidism","enrollment":1000},{"nctId":"NCT06540469","phase":"NA","title":"Iodine Supplementation in Graves' Hyperthyroidism","status":"NOT_YET_RECRUITING","sponsor":"Shandong Provincial Hospital","startDate":"2024-08-01","conditions":"Graves Disease, Hyperthyroidism","enrollment":315},{"nctId":"NCT06327828","phase":"NA","title":"Methimazole in Graves' Disease - Comparing the Computer-aided Treatment DigiThy Versus Usual Care","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Graz","startDate":"2024-09-01","conditions":"Graves Disease","enrollment":52},{"nctId":"NCT06068179","phase":"PHASE2, PHASE3","title":"Graves' Disease Remission Study: MycoMeth Combo","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2023-10-16","conditions":"Graves' Disease","enrollment":205},{"nctId":"NCT05461820","phase":"PHASE4","title":"Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-05-01","conditions":"Graves Disease, Relapse, Treatment","enrollment":240},{"nctId":"NCT03064542","phase":"","title":"The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure","status":"COMPLETED","sponsor":"Singapore Institute of Food and Biotechnology Innovation","startDate":"2015-10-13","conditions":"Hyperthyroidism","enrollment":30},{"nctId":"NCT04776993","phase":"PHASE3","title":"A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy","status":"UNKNOWN","sponsor":"University of Pisa","startDate":"2023-03-02","conditions":"Graves' Orbitopathy","enrollment":52},{"nctId":"NCT05017610","phase":"EARLY_PHASE1","title":"Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2021-10-20","conditions":"Recurrent Glioblastoma, Recurrent Gliosarcoma","enrollment":""},{"nctId":"NCT05118542","phase":"PHASE3","title":"Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-01-01","conditions":"Hyperthyroidism, Graves Disease, Atherosclerosis of Artery","enrollment":36},{"nctId":"NCT05043233","phase":"","title":"Observation in the Treatment of Graves' Disease","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-10-01","conditions":"Patient Acceptance of Health Care","enrollment":1000},{"nctId":"NCT04135573","phase":"","title":"The Relationship Between NK Cell and Graves' Disease","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2018-10-15","conditions":"Graves Disease","enrollment":200},{"nctId":"NCT04346901","phase":"PHASE1","title":"Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma","status":"COMPLETED","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2019-08-01","conditions":"Melasma, Hyperthyroidism","enrollment":23},{"nctId":"NCT04304794","phase":"","title":"Iodinated Contrast Media Induced Hyperthyroidism","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2015-01-02","conditions":"Hyperthyroidism/Thyrotoxicosis, Hyperthyroidism; Goiter, Iodine Induced Thyrotoxicosis","enrollment":36},{"nctId":"NCT02654041","phase":"PHASE2","title":"Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients","status":"TERMINATED","sponsor":"Musli Thyropeutics Ltd.","startDate":"2016-03","conditions":"Glioblastoma Multiforme (GBM)","enrollment":3},{"nctId":"NCT03447093","phase":"","title":"The Oral Microbiota is Associated With Autoimmune Thyroiditis","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2017-12-23","conditions":"Microbiota","enrollment":120},{"nctId":"NCT03433352","phase":"","title":"Intestinal Microbiota and Treatment of GD","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2017-12-23","conditions":"Microbiota","enrollment":90},{"nctId":"NCT03390582","phase":"","title":"Gut Microbiota is Associated With Autoimmune Thyroid Disease","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","startDate":"2017-04-20","conditions":"Gut Microbiota","enrollment":200},{"nctId":"NCT03066076","phase":"PHASE3","title":"Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2017-03-01","conditions":"Graves Disease, Graves Ophthalmopathy, Graves' Ophthalmopathy Worsened","enrollment":60},{"nctId":"NCT02812888","phase":"","title":"Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism","status":"UNKNOWN","sponsor":"Hu Hao","startDate":"2016-07","conditions":"Hyperthyroidism","enrollment":240},{"nctId":"NCT02727738","phase":"NA","title":"Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole","status":"COMPLETED","sponsor":"University of Pisa","startDate":"2014-01","conditions":"Graves' Disease","enrollment":30},{"nctId":"NCT01458600","phase":"PHASE4","title":"Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)","status":"COMPLETED","sponsor":"Mikael Lantz","startDate":"2006-09","conditions":"Graves´ Disease","enrollment":65},{"nctId":"NCT01247077","phase":"PHASE2","title":"Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient?","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2008-11","conditions":"QoL Before and After 9 Month of Medical Treatment of Graves´Thyrotoxicosis, Potential Effect of Selenium","enrollment":44},{"nctId":"NCT02376088","phase":"","title":"Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease","status":"COMPLETED","sponsor":"Weikai Hou","startDate":"2011-06","conditions":"Graves Disease","enrollment":328},{"nctId":"NCT00150124","phase":"PHASE4","title":"Block-replacement Therapy During Radioiodine Therapy","status":"COMPLETED","sponsor":"Steen Bonnema","startDate":"2003-01","conditions":"Toxic Nodular Goitre, Graves' Disease","enrollment":100},{"nctId":"NCT01893450","phase":"NA","title":"Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment","status":"TERMINATED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2008-06","conditions":"Graves Ophthalmopathy","enrollment":31},{"nctId":"NCT01849861","phase":"PHASE4","title":"Cardiopulmonary Capacity in Elderly With Different Ranges of Serum Thyroid Stimulating Hormone","status":"UNKNOWN","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2011-09","conditions":"Healthy","enrollment":200},{"nctId":"NCT00917241","phase":"PHASE4","title":"Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone","status":"COMPLETED","sponsor":"Xiao-Ming Mao","startDate":"2004-06","conditions":"Graves' Disease","enrollment":218},{"nctId":"NCT01560299","phase":"NA","title":"Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","startDate":"2010-02","conditions":"Graves Disease","enrollment":150},{"nctId":"NCT00677469","phase":"NA","title":"Low Doses of Cholestyramine in the Treatment of Hyperthyroidism","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2007-07","conditions":"Graves Disease","enrollment":45},{"nctId":"NCT00001421","phase":"PHASE2","title":"Methimazole to Treat Polymyositis and Dermatomyositis","status":"COMPLETED","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"1995-06","conditions":"Dermatomyositis, Polymyositis","enrollment":20},{"nctId":"NCT00150111","phase":"PHASE1, PHASE2","title":"Rituximab in the Treatment of Graves' Disease","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2003-06","conditions":"Graves´ Disease, Thyroid Associated Ophthalmopathy","enrollment":20},{"nctId":"NCT00150137","phase":"PHASE4","title":"Antithyroid Drugs During Radioiodine Therapy","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2003-01","conditions":"Toxic Nodular Goitre, Graves Disease","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":20,"reaction":"ANAEMIA"},{"count":17,"reaction":"DYSPNOEA"},{"count":15,"reaction":"FATIGUE"},{"count":15,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":15,"reaction":"HYPERTHYROIDISM"},{"count":15,"reaction":"PYREXIA"},{"count":13,"reaction":"NAUSEA"},{"count":13,"reaction":"PNEUMONIA"},{"count":11,"reaction":"DIARRHOEA"},{"count":11,"reaction":"DIZZINESS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":28,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Thiamazol","genericName":"Thiamazol","companyName":"Dr.dr.Irma Bernadette, SpKK (K)","companyId":"dr-dr-irma-bernadette-spkk-k","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Thiamazol is a small molecule that acts as a thyroid peroxidase inhibitor. It is used to treat conditions such as Graves' disease and hyperthyroidism, and has been studied in clinical trials for its effects on quality of life and the potential benefits of iodine supplementation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}